These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8446653)

  • 1. Effect of pravastatin on fatty acid profile of low density lipoprotein in patients with hypercholesterolemia.
    Hong CY; Lin SJ; Chang MS; Chiang BN; Shen PM; Shiao MS
    Prostaglandins Leukot Essent Fatty Acids; 1993 Feb; 48(2):155-8. PubMed ID: 8446653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
    Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
    Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linoleic acid lowers LDL cholesterol without a proportionate displacement of saturated fatty acid.
    Rassias G; Kestin M; Nestel PJ
    Eur J Clin Nutr; 1991 Jun; 45(6):315-20. PubMed ID: 1915205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of statins on circulating oxidized low-density lipoprotein in patients with hypercholesterolemia.
    Inami S; Okamatsu K; Takano M; Takagi G; Sakai S; Sano J; Mizuno K
    Jpn Heart J; 2004 Nov; 45(6):969-75. PubMed ID: 15655272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pravastatin on serum lipids, apolipoproteins and lipoprotein (a) in patients with non-insulin dependent diabetes mellitus.
    Umeda F; Watanabe J; Inoue K; Hisatomi A; Mimura K; Yamauchi T; Sako Y; Kunisaki M; Tajiri Y; Nawata H
    Endocrinol Jpn; 1992 Feb; 39(1):45-50. PubMed ID: 1535040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesteryl ester transfer in hypercholesterolaemia: fasting and postprandial studies with and without pravastatin.
    Contacos C; Barter PJ; Vrga L; Sullivan DR
    Atherosclerosis; 1998 Nov; 141(1):87-98. PubMed ID: 9863541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pravastatin modulates cholesteryl ester transfer from HDL to apoB-containing lipoproteins and lipoprotein subspecies profile in familial hypercholesterolemia.
    Guérin M; Dolphin PJ; Talussot C; Gardette J; Berthézène F; Chapman MJ
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1359-68. PubMed ID: 7670950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. I. A dose-response study.
    Hunninghake DB; Knopp RH; Schonfeld G; Goldberg AC; Brown WV; Schaefer EJ; Margolis S; Dobs AS; Mellies MJ; Insull W
    Atherosclerosis; 1990 Nov; 85(1):81-9. PubMed ID: 2126437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).
    Jones P; Kafonek S; Laurora I; Hunninghake D
    Am J Cardiol; 1998 Mar; 81(5):582-7. PubMed ID: 9514454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of fluvastatin (XU 62-320), an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humans.
    Yuan JN; Tsai MY; Hegland J; Hunninghake DB
    Atherosclerosis; 1991 Apr; 87(2-3):147-57. PubMed ID: 1854361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent hypolipidemic effect of an inhibitor of HMG-CoA reductase, pravastatin (CS-514), in hypercholesterolemic subjects. A double blind test.
    Saito Y; Goto Y; Nakaya N; Hata Y; Homma Y; Naito C; Hayashi H; Ito H; Yamamoto M; Takeuchi I
    Atherosclerosis; 1988 Aug; 72(2-3):205-11. PubMed ID: 3145746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of one year of treatment with pravastatin, an HMG-CoA reductase inhibitor, on lipoprotein a.
    Hunninghake DB; Stein EA; Mellies MJ
    J Clin Pharmacol; 1993 Jun; 33(6):574-80. PubMed ID: 8366183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies.
    Hoffman R; Brook GJ; Aviram M
    Atherosclerosis; 1992 Mar; 93(1-2):105-13. PubMed ID: 1596293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pravastatin effects on lipoproteins, Lp (a), apo B and apo A-1 in patients with primary hypercholesterolemia].
    Novazzi JP; Fonseca FA; Feres MC; da Silva RC; Lima JC; Martinez TL
    Arq Bras Cardiol; 1994 Jun; 62(6):395-8. PubMed ID: 7826229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of simvastatin and pravastatin on gonadal function in male hypercholesterolemic patients.
    Dobs AS; Miller S; Neri G; Weiss S; Tate AC; Shapiro DR; Musliner TA
    Metabolism; 2000 Jan; 49(1):115-21. PubMed ID: 10647074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lipoprotein changes after treatment with pravastatin and gemfibrozil in patients with familial hypercholesterolemia.
    Franceschini G; Sirtori M; Vaccarino V; Gianfranceschi G; Chiesa G; Sirtori CR
    J Lab Clin Med; 1989 Sep; 114(3):250-9. PubMed ID: 2504855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined therapy with probucol and pravastatin in hypercholesterolaemia. One year follow-up study.
    Saku K; Zhang B; Hirata K; Okura Y; Bai H; Liu R; Arakawa K
    Eur J Clin Pharmacol; 1993; 44(6):535-9. PubMed ID: 8405008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The susceptibility of low-density lipoprotein to in vitro oxidation is increased in hypercholesterolemic patients.
    Cominacini L; Pastorino AM; Garbin U; Campagnola M; de Santis A; Davoli A; Faccini G; Bertozzo L; Pasini F; Pasini AF
    Nutrition; 1994; 10(6):527-31. PubMed ID: 7703599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of atorvastatin and pravastatin on malondialdehyde-modified LDL in hypercholesterolemic patients.
    Tamura A; Watanabe T; Nasu M
    Circ J; 2003 Oct; 67(10):816-20. PubMed ID: 14578611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia.
    Saito Y; Yamada N; Teramoto T; Itakura H; Hata Y; Nakaya N; Mabuchi H; Tushima M; Sasaki J; Ogawa N; Goto Y
    Atherosclerosis; 2002 Jun; 162(2):373-9. PubMed ID: 11996957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.